Evidence map›Paper›PMID 42140430›Full record

ArticleThe Journal of biological chemistry2026

Functional characterization of UHRF1 variants in facilitating DNA methylation.

Bigang Liu, Kaila Nayvelt, Swanand Hardikar, Kimie Kondo, Marcos R Estecio, Xiaodong Cheng, Taiping Chen

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bigang LiuDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kaila NayveltDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Swanand HardikarDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kimie KondoDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marcos R EstecioDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Xiaodong ChengDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Taiping ChenDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Program in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA. Electronic address: tchen2@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Epigenetic regulations of DNA and histone methylation and deMethylation: Structures and MechanismsR35GM134744 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Xiaodong Cheng · 2020 to 2026
$4.5M
MD Anderson Summer Program in Cancer Research (SPCR)R25CA181004 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MARK T. BEDFORD, Joya Chandra · 2014 to 2026
$1.8M
Role of PRMT7 in Genomic ImprintingR01HD112473 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Taiping Chen · 2023 to 2026
$1.4M
NCI NIH HHS P30 CA016672NCI NIH HHS R25 CA181004NICHD NIH HHS R01 HD112473NIGMS NIH HHS R35 GM134744
6 · The paper itself

Abstract

Ubiquitin-like with plant homeodomain (PHD) and really interesting new gene (RING) finger domains 1 (UHRF1) is essential for DNA methylation inheritance. However, the functional impacts of several natural and engineered UHRF1 variants are either insufficiently characterized or obscured by conflicting results, with some discrepancies likely stemming from cellular toxicity and adaptive responses induced by DNA methylation changes. In this study, we utilized mouse embryonic stem cells (mESCs)-which uniquely tolerate the complete loss of DNA methylation-to evaluate the functional consequences of clinical mutations, isoform variation, and epitope tagging. Using rescue experiments in Uhrf1-deficient mESCs, we characterized two UHRF1 mutations identified in a patient with immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome, demonstrating that the R618X nonsense mutation creates a null allele, while the R296W missense mutation is hypomorphic. Furthermore, we confirmed that N-terminal tagging abolishes UHRF1 function, whereas human UHRF1 (hUHRF1) isoform 2, featuring a 13-residue N-terminal extension, is functionally inactive. AlphaFold3 structural predictions suggest that these additional residues at the N terminus disrupt essential inter-domain interactions. Collectively, our results define the activity of UHRF1 variants and resolve existing inconsistencies in the field.

Indexed as

CCAAT-Enhancer-Binding ProteinsDNA MethylationAnimalsHumansMiceMouse Embryonic Stem CellsMutationUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsUbiquitin-Protein LigasesUHRF1 protein, humanUhrf1 protein, mouse5-methylcytosineDNA methylationDNA methyltransferaseembryonic stem cellepigeneticsepitope tagICF syndromeUHRF1

Identifiers

PMID42140430
PMCPMC13264223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.